Keyword Connections

montelukast

Journals

7

1 Applied and environmental microbiology

2 Journal of microbiology (Seoul, Korea)

3 pediatric nephrology (berlin, germany)

4 mmwr morbidity and mortality weekly report

5 emotion (washington, dc)

6 Pulmonary pharmacology & therapeutics

7 current allergy and asthma reports

Research Groups

0

No Research Group Connected

Bibliographies

16

1 The leukotriene receptor antagonist Montelukast can induce adverse skin reactions in asthmatic patients.

2 Correction to: Eplet mismatch analysis and allograft outcome across racially diverse groups in a pediatric transplant cohort: a single-center analysis.

3 Yeast viral killer toxin K1 induces specific host cell adaptions via intrinsic selection pressure.

4 Progress Toward Measles Elimination - China, January 2013-June 2019.

5 QuickStats: Percentage* of Adults Aged 18-64 Years Who Had Seen or Talked to a Health Care Professional in the Past 12 Months, by Race/Ethnicity - National Health Interview Survey, 2012-2013 and 2017-2018.

6 "Implications of emotion regulation strategies for empathic concern, social attitudes, and helping behavior": Correction to Lebowitz and Dovidio (2015).

7 Correction to: Basophil Activation Test: Old and New Applications in Allergy.

8 Status of HIV Case-Based Surveillance Implementation - 39 U.S. PEPFAR-Supported Countries, May-July 2019.

9 Erratum: Vol. 68, No. 43.

10 Erratum to: Flavobacterium parvum sp. nov., isolated from soil polluted by sewer water.

11 montelukast in adenoid hypertrophy: its effect on size and symptoms

12 effect of depression on renal function as well as oxidative stress and inflammatory response in patients with diabetic nephropathy

13 Development of a biocatalytic process as an alternative to the (-)-DIP-Cl-mediated asymmetric reduction of a key intermediate of montelukast

14 Phase 2 trial of montelukast for prevention of pain in sickle cell disease.

15 novel lc method development and validation for simultaneous determination of montelukast and doxofylline in bulk and pharmaceutical dosage forms

16 Montelukast reduces ischaemia/reperfusion-induced bladder dysfunction and oxidant damage in the rat.